Navigation Links
NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
Date:5/18/2009

Milestone Payment from Alcon and Initial Payments from New Galderma Collaboration Resulted in Positive Cash-Flow for the Quarter

EMERYVILLE, Calif., May 18 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY), a mid-stage biopharmaceutical company developing first-in-class anti-infective products for the treatment and prevention of a wide range of infections without causing resistance, reported today its financial results and operational highlights for the first quarter of 2009 ended March 31, 2009.

License and collaboration revenue for the first quarter of 2009 increased 75% to $2.6 million from $1.5 million for the first quarter of 2008. This revenue consisted almost exclusively of amounts earned under license and collaboration agreements with Alcon, Inc. (NYSE: ACL), a leader in the discovery, development, and commercialization of pharmaceutical products, in particular for the treatment of eye and ear infections and for contact lens care, commencing in August of 2006, and most recently, Galderma S.A, the leading dermatology company in the world. Payments from Alcon were related to on-going research and development support and a milestone payment triggered by the clearance of an Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). During this quarter, a license agreement and collaboration was entered into with Galderma S.A., a leader in the discovery, development, and commercialization of pharmaceutical products and medical devices for the prevention and treatment of skin diseases, for the development of the Aganocide(R) compounds for certain dermatological indications. Under the terms of the agreement, NovaBay received an initial payment and also the first of committed month
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. NovaBay Pharmaceuticals Scientific Advisor Receives American Chemical Societys Highest Award
2. NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting
3. NovaBay announces third quarter 2007 financial results
4. NovaBay Pharmaceuticals Closes Initial Public Offering of Common Stock
5. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
6. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for its Third Quarter of FY 2009
7. Jiangbo Pharmaceuticals, Inc. to Present at CCG IRs China Rising Conference in New York
8. Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
9. Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name
10. Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
11. Alseres Pharmaceuticals, Inc. Receives Notice of De-Listing of Its Securities for Failure to Regain Compliance with Continued Listing Requirements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... more likely to insert them , , TUESDAY, Feb. 9 ... set up to make a profit are more likely ... despite evidence that the practice does not prolong life ... "Our results suggest that decisions about feeding tubes are ... decision-making process that really elicits and supports patient choice," ...
(Date:2/9/2010)... for the Heart ... CHICAGO , Feb. 9 Show ... a gift for the heart with the ... Flavorful Recipes Made with Canola Oil" by the American ... of these recipes for love or give the cookbook ...
(Date:2/9/2010)... Center have found a direct link between neighborhood ... in African American women. The study, which appears ... , is the first prospective study to examine ... of type 2 diabetes in a large, geographically ... diabetes is estimated to affect 20.6 million people ...
(Date:2/9/2010)... Passage of Problem-Riddled Health Freedom Act Could See Idaho Lose ... ,, BOISE, Idaho , Feb. 9 ... the groundwork to oppose a non-existent federal health care law, ... years to come.  AARP is calling the Idaho Health Freedom ... legislation that, if signed into law, could see Idaho ...
(Date:2/9/2010)... two or more soft drinks per week increased the ... with individuals who did not consume soft drinks, according ... Prevention , a journal of the American Association for ... remains one of the most deadly; only 5 percent ... , Mark Pereira, Ph.D., senior author on the study ...
Breaking Medicine News(10 mins):Health News:Too Many With End-Stage Dementia Get Feeding Tubes 2Health News:Too Many With End-Stage Dementia Get Feeding Tubes 3Health News:Cook With Love This Valentine's Day With Heart-Smart Recipes 2Health News:Cook With Love This Valentine's Day With Heart-Smart Recipes 3Health News:Neighborhood socioeconomic status and diabetes 2Health News:Idaho House Moves State Closer to Health Care Disaster 2Health News:Idaho House Moves State Closer to Health Care Disaster 3Health News:Idaho House Moves State Closer to Health Care Disaster 4Health News:Soft drinks may increase risk of pancreatic cancer 2
... December, New York City passed a law to phase out ... Boston and Chicago, might follow suit. //According to Alice H. ... the Friedman School of Nutrition Science and Policy at Tufts ... but restaurateurs need to replace partially hydrogenated fat with unsaturated ...
... drugs, but have turned to prescription painkillers, which are dangerous, ... at Northern Westchester Hospital Center, in Mount Kisco, N.Y said, ... prescriptions for potentially legitimate uses for parents, it provides access ... out and procure illicit drugs." ,The MTF survey ...
... A 61-year-old cancer patient developed a lesion under ... were perplexed, as the biopsy showed a new ... had been injecting herself with extract of mistletoe,thrice ... is published in the British Medical Journal (BMJ). ...
... India constitute more than one-sixth of the world's ... related //to genetic diseases. And with the growth ... and western lifestyles have risen to near-epidemic proportions, ... importance. ,In response to this dearth ...
... study comparing the safety, effectiveness and reliability of LASIK and ... types of laser eye// surgery. ,The study, led ... in the December 2006 issue of the American Journal of ... the safety and efficacy of both types of laser surgery, ...
... study recently published online by Developmental Biology, members of ... Health System report the discovery// of a new protein ... target for male contraceptive drugs. ,“There’s considerable ... heads UVa’s Center for Research in Contraceptive and Reproductive ...
Other Medicine News:Health News:Trans Fat Ban: Watch Saturated Fats and Calories Too 2Health News:Trans Fat Ban: Watch Saturated Fats and Calories Too 3Health News:Researchers Make Progress in Studying Genetic Traits of India-born Populations 2Health News:Study Compares LASIK and LASEK Eye Surgery 2Health News:Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers 2
(Date:2/9/2010)... 9 Glycemion Strategies, Inc., an ... for diabetic consumers and their professional healthcare providers, ... Program to benefit the 30,000 US Diabetes Educators ... they serve. ,, The Portrait Health™ ... to provide real-time access to health information, especially ...
(Date:2/9/2010)... Feb. 9 Takeda Global ... announced today that it has initiated a trial ... pump inhibitors (PPIs) affect the pharmacokinetics and pharmacodynamics ... has been evaluating all published data and communications ... regarding the potential risks associated with concomitant use ...
(Date:2/9/2010)... Feb. 9 SIRO Clinpharm, a ... India , Western and Central Eastern Europe, ... its alliance with DreamCIS Inc., a leading CRO ... ,, DreamCIS has nearly a decade of experience ... bio venture companies, medical device manufacturers, and functional ...
Breaking Medicine Technology:Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 2Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 3Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate) 2Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate) 3Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate) 4SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 2SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 3NeurogesX to Present at Two November Conferences 14641 1NeurogesX to Present at Two November Conferences 14641 2NeurogesX to Present at Two November Conferences 14641 3Echo Therapeutics Announces Significant Advance in Development of its One Piece Needle Free Symphony tCGM Biosensor 5825 1Echo Therapeutics Announces Significant Advance in Development of its One Piece Needle Free Symphony tCGM Biosensor 5825 2Echo Therapeutics Announces Significant Advance in Development of its One Piece Needle Free Symphony tCGM Biosensor 5825 3Global Spinal Nonfusion Market to Reach Almost 242 Billion By 2013 According to Millennium Research Group 5822 1Global Spinal Nonfusion Market to Reach Almost 242 Billion By 2013 According to Millennium Research Group 5822 2Global Spinal Nonfusion Market to Reach Almost 242 Billion By 2013 According to Millennium Research Group 5822 3
... An independent team of,scientists is leading Alzheimer,s disease ... million grant they received last year from,Alzheimer,s Disease ... (AHAF), Donald F. Weaver, M.D., Ph.D. and his ... are leading a,multi-site, multidisciplinary international effort to design ...
... Cooling Device to Treat Heart Attack,Victims, WALDWICK, ... a competitively awarded $700,000 grant from the National,Institutes ... to investigate the,feasibility of cooling heart attack patients ... cold water immersion to rapidly lower patient,temperature., ...
Other Medicine Technology:Aiming at Multiple Alzheimer's Proteins May be Key to Success 2Aiming at Multiple Alzheimer's Proteins May be Key to Success 3Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: